Editorial board disclosure policy
(Last updated January 2025)
All editors responsible for recommending or making publication decisions are requested to disclose on an annual basis any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content.
The following competing interests were disclosed:
Professor Matthew D Ringel (Editor-in-Chief)
Professor Ringel has received research grants from NIH and the United States Department of Defense. He has received lecture fees from the Society for Endocrinology (SFE) and Latin American Tumor Society (LATS). Professor Ringel is also on the editorial board for JCI Insight.
Professor Ringel has received research grants from NIH and the United States Department of Defense. He has received lecture fees from the Society for Endocrinology (SFE) and Latin American Tumor Society (LATS). Professor Ringel is also on the editorial board for JCI Insight.
Professor Márta Korbonits (Deputy Editor)
Professor Korbonits has received grant and consultancy fees from Pfizer, Recordati, ONO, Crinetics, and NovoNordisk. Professor Korbonits is also on the editorial board for The Journal of Clinical Endocrinology and Metabolism and Pituitary.
Professor Korbonits has received grant and consultancy fees from Pfizer, Recordati, ONO, Crinetics, and NovoNordisk. Professor Korbonits is also on the editorial board for The Journal of Clinical Endocrinology and Metabolism and Pituitary.
Professor Emily Bergsland
Professor Bergsland has received research grants from Merck and RayzeBio, Inc. She also receives royalties from UpToDate, Inc.
Professor Lisa Butler
Professor Butler has received materials from Envision Sciences Pty Ltd. She holds the following patents: WO03/070 & US2003235588, PCT/AU/2014/000612, 15/794,270, and PCT/AU2020/050925. She is on the editorial board for Molecular Cancer Research.
Dr Man-Ho Choi
Dr Choi is on the editorial board for Journal of Steroid Biochemistry and Molecular Biology.
Dr Robert Clarke
Dr Clarke is a paid consultant for ARNA Genomics, Inc; American Gene Technologies Inc; Bayer Pharmaceuticals and MN Pharma. Dr Clarke receives licensing fees from Georgetown University for cell lines when licensed to non-academic institutions. He also holds the following patents: 07/620,853 & 5,091,423; 08/667,542 & 9692250.7; 2,012,138,715 & 12/032110; 2,013,040,393 & 14/344,773.
Dr Clarke is a paid consultant for ARNA Genomics, Inc; American Gene Technologies Inc; Bayer Pharmaceuticals and MN Pharma. Dr Clarke receives licensing fees from Georgetown University for cell lines when licensed to non-academic institutions. He also holds the following patents: 07/620,853 & 5,091,423; 08/667,542 & 9692250.7; 2,012,138,715 & 12/032110; 2,013,040,393 & 14/344,773.
Professor Antonio Di Cristofano
Professor Di Cristofano has a sponsored research agreement with THRYV therapeutics.
Professor Di Cristofano has a sponsored research agreement with THRYV therapeutics.
Dr Judith Favier
Dr Favier holds the patents 18,306,527.5 and EP2019/081848 on 'Methods for predicting metastatic potential in patients suffering from sdhb-mutated paraganglioma'.
Dr Favier holds the patents 18,306,527.5 and EP2019/081848 on 'Methods for predicting metastatic potential in patients suffering from sdhb-mutated paraganglioma'.
Dr Lauren Fishbein
Dr Fishbein is on the editorial board for Endocrine Reviews.
Professor Paramita Ghosh
Professor Ghosh has received research grants from the National Institutes of Health, USA, Department of Veterans Affairs, and is employed by the University of California Davis. She is on the editorial board for Scientific Reports and Cellular and Molecular Life Sciences.
Professor Ghosh has received research grants from the National Institutes of Health, USA, Department of Veterans Affairs, and is employed by the University of California Davis. She is on the editorial board for Scientific Reports and Cellular and Molecular Life Sciences.
Professor Wouter de Herder
Professor de Herder has received speaker fees from Novartis-AAA, Camurus, and Ipsen, as well as financial research support from Ipsen and AAA-Novartis. He is on the editorial board for Endotext and Journal of Neuroendocrinology.
Professor de Herder has received speaker fees from Novartis-AAA, Camurus, and Ipsen, as well as financial research support from Ipsen and AAA-Novartis. He is on the editorial board for Endotext and Journal of Neuroendocrinology.
Professor Dr Peter Igaz
Professor Dr Igaz has received honoraria from Ipsen, HRA Pharma, and Recordati. He has also received travel expenses from Ipsen, Merck, and Novo Nordisk. Prof. Dr. Igaz holds patents on 'Tissue microRNA combinations for the diagnosis of adrenocortical tumor malignancy' and 'Differential diagnosis of primary aldosteronism'. He is on the editorial board for Hungarian Medical Journal, Frontiers in Genetics, and American Journal of Cancer Research.
Professor Deborah Marsh
Professor Marsh has received grants from the Australian National Health & Medical Research Council (NHMRC), Cancer Council NSW (CCNSW) and Medical Research Future Fund (MRFF). She is on the editorial board for Cancers and Human Molecular Genetics, and receives honoraria for the latter.
Professor Marsh has received grants from the Australian National Health & Medical Research Council (NHMRC), Cancer Council NSW (CCNSW) and Medical Research Future Fund (MRFF). She is on the editorial board for Cancers and Human Molecular Genetics, and receives honoraria for the latter.
Professor Lois Mulligan
Professor Mulligan serves as the Chair of the Scientific Review and Research Committee, North American Neuroendocrine Tumor Society.
Dr Joanne Ngeow
Dr Ngeow is the recipient of research grants from AstraZeneca and Mirxes.
Dr Ngeow is the recipient of research grants from AstraZeneca and Mirxes.
Professor Martin Schlumberger
Professor Schlumberger is on the editorial board for Endocrine.
Professor Constantine Stratakis
Professor Stratakis has Directorship of the new Research Institute, ELPEN SA, on genetics and personalized medicine. He has also received research funding from Pfizer, Inc as well as consulting fees for ELPEN, Sterotherapeutics, Sandoz, Lundbeck pharmaceuticals. Professor Statakis has received employment and editorial fees from Molecular & Cellular Endocrinology and Hormones, of which he holds editorial positions. He holds patents on PDE11A, PRKAR1A, and GPR101 gene function.
Professor Christine Spitzweg
Professor Spitzweg has received lecture and consultancy fees from Eli Lilly, IPSEN, Eisai Co., Bayer AG, Roche, and Sanofi SA. She has also received travel expense fees from IBSA Pharma Inc.
Professor Wayne Tilley
Professor Tilley has received research grants from the Australian National Health & Medical Research Council (NHMRC) and Ellipses Pharma.
Bioscientifica staff and freelancers working on the journal reported no conflicts of interest. Article authors' declarations are stated in each journal article. Referees must disclose any competing interests before agreeing to review any submission. For more information on the journal’s ethical policy, please read the ethical guidelines.
This policy follows the recommendations of the International Committee of Medical Journals Editors (ICMJE) and the Committee on Publication Ethics (COPE).
